A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS)
Neurourology and Urodynamics · 2023-03 · 42 (3) · 615-622
DOI: 10.1002/nau.25142 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neurourology and Urodynamics, online erschienen am 06.02.2023. Verfasst von Nani P Moss und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Urogynecology, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Skokie, Illinois, USA. Hauptthemen laut MEDLINE: Cystitis, Interstitial, Nocturia. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction and Hypothesis The primary aim of this study was to compare the effect of bladder instillations using dimethyl sulfoxide (DMSO) with triamcinolone versus bupivacaine, triamcinolone, and heparin (BTH) in women with newly diagnosed interstitial cystitis/painful bladder syndrome. The primary outcome was improvement in symptoms measured using the O'Leary‐Sant Interstitial Cystitis Symptoms Index (ICSI) score. Secondary comparisons included changes in urinary frequency, nocturia, and bladder capacity. Materials and Methods This was a prospective, randomized study. Patients with a recent diagnosis of interstitial cystitis/painful bladder syndrome (IC/PBS) were randomized 1:1 to treatment with either 6 weekly bladder instillations of DMSO with triamcinolone or BTH. During follow‐up visits, patients completed the ICSI questionnaire, and bladder capacity was determined through the retrograde filling of the bladder. The χ 2 test or Student's t test were used for data analysis.
Results
A total of 83 patients were randomized, and final analysis included 70 participants who completed the 6 weekly instillations (42 DMSO, 28 BTH). The groups were similar in baseline demographics and clinical characteristics, except for cystometric maximum capacity (DMSO 338.62± 139.44 mL, BTH 447.43 ± 180.38 mL, p = 0.01). In the DMSO group, 63% of patients had a greater than 29.5% reduction in total ICSI score versus 43% in the BTH group ( p = 0.15). Nocturia and pain were significantly reduced in the DMSO group. There was a significant increase from baseline in bladder capacity for both groups.
Conclusion
In women with newly diagnosed IC/PBS, bladder instillations with DMSO and triamcinolone provide greater improvement in pain and nocturia compared to BTH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Urogynecology, NorthShore University HealthSystem, University of Chicago Pritzker School of Medicine, Skokie, Illinois, USA.
- NorthShore University HealthSystem Research Institute, Evanston, Illinois, USA.
ORCID-Profile: Henry H Chill, Peter K Sand
Zitieren
APA
Moss, N. P., Chill, H. H., Sand, P. K., Chang, C., Goldberg, R. P., & Gafni-Kane, A. (2023). A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS). Neurourology and Urodynamics, 42(3), 615-622. https://doi.org/10.1002/nau.25142
Vancouver
Moss NP, Chill HH, Sand PK, Chang C, Goldberg RP, Gafni-Kane A. A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS). Neurourology and Urodynamics. 2023;42(3):615-622. doi:10.1002/nau.25142
BibTeX
@article{Moss2023,
author = {Moss, Nani P and Chill, Henry H and Sand, Peter K and Chang, Cecilia and Goldberg, Roger P and Gafni-Kane, Adam},
title = {A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS)},
journal = {Neurourology and Urodynamics},
year = {2023},
volume = {42},
number = {3},
pages = {615--622},
doi = {10.1002/nau.25142}
}
EUVIMED